The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat

Toxicology

Volumn 196, Issue 1-2, 2004, Pages 95-116

  Butenhoff, John L ^a   Kennedy Jr , Gerald L ^b   Frame, Steven R ^b   O'Connor, John C ^b   York, Raymond G ^c  

^a 3M COMPANY   (United States)

^b DUPONT COMPANY   (United States)

^c Argus Research Laboratories Inc   (United States)

Author keywords

Ammonium perfluorooctanoate (APFO); Multi generation; Perfluorooctanoate (PFOA); Reproduction

Indexed keywords

AMMONIUM DERIVATIVE; OCTANOIC ACID; PERFLUOROOCTANOATE AMMONIUM; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; BODY WEIGHT; CONTROLLED STUDY; ESTRUS; EVALUATION; FEMALE; FERTILITY; HISTOPATHOLOGY; LACTATION; LIVER WEIGHT; MALE; MATING; MORTALITY; NATURAL CHILDBIRTH; NONHUMAN; PRIORITY JOURNAL; PROGENY; RAT; REPRODUCTIVE TOXICITY; SEPARATION TECHNIQUE; SEXUAL MATURATION; SPERM; SPERMATOZOON COUNT; WEANING;

EID: 1242271307     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2003.11.005     Document Type: Article

References (73)

1. Alexander, B.J., 2001. Mortality of workers employed at the 3M Cottage grove facility. Minneapolis, MN: University of Minnesota. USEPA Public Docket AR-226-1030a018. Washington, DC: U.S. Environmental Protection Agency.
2. Ashby J., LeFevre P.A. The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, estrogens, and metabolic modulators. J. Appl. Toxicol. 20:2000;35-47.
3. Biegel L.B., Liu R.C.M., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol. Appl. Pharmacol. 134(1):1995;18-25.
4. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 60:2001;44-55.
5. Buist S.C.N., Cherrington N.J., Choudhuri S., Hartley D.P., Klassen C.D. Gender-specific and developmental influences on the expression of rat organic anion transporters. J. Exp. Pharmacol. Ther. 301:2003;145-152.
6. Burris, J.M., Lundberg, J.K., Olsen, G., Simpson, C., Mandel, J., 2002. Interim Report No. 2. Determination of Serum Half-Lives of Several Fluorochemicals. 3M Company, St. Paul, MN, US EPA Public Docket AR-226-1086.
7. Butenhoff J., Costa G., Elcombe C., Farrar D., Hansen K., Iwai H., Jung R., Kennedy G., Lieder P., Olsen G., Thomford P. Toxicity of ammonium perfluorooctanoate (APFO) in male cynomolgus monkeys after oral dosing for six months. Toxicol. Sci. 69:2002a;244-257.
8. Butenhoff J.L., York R., Seacat A.M., Leubker D.J. Perfluorooctanesulfonate-induced perinatal mortality in rat pups is associated with a steep dose-response. Toxicol. Sci. 66(S-1):2002b;25. (Abstract 120).
9. Carney E.W., Scortichini B.S., Crissman J.W. Feed restriction during in utero and neonatal life: effects on reproductive and developmental endpoints in the CD rat. Toxicologist. 42:1998;102-103.
10. Christian M.S., McCarty R.J., Cox-Sica D.K., Cao C.P. Recent increases in the incidences of skull, lung and rib alterations in vehicle control New Zealand white rabbits. J. Am. Coll. Toxicol. 6:1987;562.
11. Clark, R.L., 1999. Endpoints of reproductive system development. In: An Evaluation and Interpretation of Reproductive Endpoints for Human Risk Assessment. International Life Sciences Institute, Health and Environmental Science Institute, Washington, DC, pp. 27-62.
12. Deslypere J.P., Verdonck L., Vermeulen A., Clin J. Fat tissue a steroid reservoir and site of steroid metabolism. Endocrinol. Metab. 61:1985;564-570.
13. Diaz M.J., Chinje E., Kentish P., Jarnot B., George M., Gibson G. Induction of cytochrome P4504A by the peroxisome proliferator perfluoro-n-octanoic acid. Toxicology. 86(1/2):1994;109-122.
14. Dunn O.J. Multiple comparisons using rank sums. Technometrics. 6:1964;241-252.
15. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
16. Feron V.J., de Groot A.P., Spanjers M.T., Til H.P. An evaluation of the criterion "organ weight" under conditions of growth retardation. Food Cosmet. Toxicol. 11(1):1973;85-94.
17. Fitzgerald J.E., Petrere J.A., de-la-Iglesia F.A. Experimental studies on reproduction with the lipid-regulating agent gemfibrozil. Fundam. Appl. Toxicol. 8:1987;454-464.
18. Gibson J.P., Larson E.J., Yarrington J.T., Hook R.H., Kariya T., Blohm T.R. Toxicity and teratogenicity studies with the hypolipidemic drug RMI 14,514 in rats. Fundam. Appl. Toxicol. 1:1981;19-25.
19. Glass A.R., Harrison R., Swerdloff R.S. Effect of undernutrition and amino acid deficiency on the timing of puberty in rats. Pediatr. Res. 10:1976;951-955.
20. Glass A.R., Swerdloff R.S. Nutritional influences on sexual maturation in the rat. Fed. Proc. 39:1980;2360-2364.
21. Gortner, E.G., 1981. Oral teratology study of T-2998CoC in rats. Safety Evaluation Laboratory and Riker Laboratories, Inc. Experiment No.: 0681TR0110, December 1981. USEPA Public Docket AR-226-0463.
22. Gortner, E.G., 1982. Oral teratology study of T-3141CoC in rabbits. Safety Evaluation Laboratory and Riker Laboratories, Inc. Experiment No.: 0681TB0398, February 1982. USEPA Public Docket AR-226-0465.
23. Hanhijarvi, H., Ylinen, M., Haaranen, T., Nevalainen, T., 1988. A proposed species difference in the renal excretion of perfluorooctanoic acid in the beagle dog and rat. In: Beyner, A.C., Solleveld, H.A. (Eds.), New Developments in Bioscience: Their Implications for Laboratory Animal Science. Martins-Nijhoff Pub., Dordrecht, The Netherlands.
24. Hansen K.J., Clemen L.A., Ellefson M.E., Johnson H.O. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35(4):2001;766-770.
25. Ikeda T., Aida K., Fukuda K., Tanaka M. The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J. Biochem. 98:1989;475-482.
26. ILAR (Institute for Laboratory Animal Research), 1991. Infectious Diseases of Mice and Rats. Committee on Infectious Diseases of Mice and Rats, Institute for Laboratory Animal Research, Commission on Life Sciences, National Research Council. National Acadamies Press, Washington, DC, p. 197.
27. Kawashima Y., Uy-Yu N., Kozuka H. Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisome β-oxidation, microsomal 1-acylglycerolphosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver. Biochem. J. 261:1989;595-600.
28. Kemper, R.A., 2003. Perfluorooctanoic Acid: Toxicokinetics in the Rat. DuPont Haskell Laboratory, Laboratory Project ID: DuPont-7473.
29. Kennedy G.C., Mitra J. Body weight and food intake as initiating factors for puberty in the rat. J. Physiol. 166:1963;408-418.
30. Kennedy, G.L., Butenhoff, J.L., Olsen, G.W., O'Connor, J.C., Seacat, A.M., Perkins, R.G., Biegel, L.B., Murphy, S.R., 2004. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. (in press).
31. Kley H.K., Deselaers T., Peerenboom H., Kruskemper H.L. Enhanced conversion of androstenedione to estrogens in obese males. J. Clin. Endocrinol. Metab. 51:1980;1128-1132.
32. Kudo N., Suzuki E., Katakuva M., Ohmori K., Noshiro R., Kawashima Y. Comparison of elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem.-Biol. Interact. 134:2001;203-216.
33. Kudo N., Katakura M., Sato Y., Kawashima Y. Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem.-Biol. Interact. 139:2002;301-316.
34. Lau C., Thibodeaux J.R., Henson R.G., Rogers J.M., Gray B.E., Stanton M.E., Butenhoff J.L., Stevenson J.A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II. Postnatal evaluation. Toxicol. Sci. 74:2003;382-392.
35. Lewis E.M., Barnett J.F., Freshwater L., Hoberman A.M., Christian M.E. Sexual maturation data for Crl Sprague-Dawley rats: criteria and confounding factors. Drug Chem. Toxicol. 25(4):2002;437-458.
36. Malinverno G., Rusch G.M., Millischer R.J., Hughes E.W., Schroeder R.E., Coombs D.W. Inhalation teratology and reproduction studies with 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123). Fundam. Appl. Toxicol. 34:1996;276-287.
37. Marty M.S., Crissman J.W., Carney E.W. Evaluation of the EDSTAC female pubertal assay in CD rats using 17β-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor. Toxicol. Sci. 52:1999;269-277.
38. Marty M.S., Crissman J.W., Carney E.W. Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats. Toxicol. Sci. 60:2001a;285-295.
39. Marty M.S., Crissman J.W., Carney E.W. Evaluation of the male pubertal onset assay's ability to detect thyroid inhibitors and dopaminergic agents. Toxicol. Sci. 60:2001b;62-76.
40. Marty M.S., Johnson K.A., Carney E.W. Effect of feed restriction on Hershberger and pubertal male assay endpoints. Toxicologist. 60:2001c;223.
41. Ohmori K., Kudo N., Katayama K., Kawashima Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain lengths. Toxicology. 184:2003;135-140.
42. Oishi S., Oishi H., Hiraga K. The effect of food restriction for 4 weeks on common toxicity parameters in male rats. Toxicol. Appl. Pharmacol. 47(1):1979;15-22.
43. Ojeda, S.R., Urbanski, H.F., 1994. Puberty in the rat. In: Knobil, E., Neil, J.D., Greewald, G.S., Markert, C.I., Pfaff, D.W. (Eds.), The Physiology of Reproduction, second ed., vol. 2. Raven Press, New York, pp. 363-409.
44. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med. 40:1998;614-620.
45. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem. Toxicol. 23:2000;603-620.
46. Olsen, G.W., Burris, J.M., Lundberg, Hansen, K.J., Mandel, J.H., Zobel, L.R., 2002a. Identification of fluorochemicals in human sera. II. Elderly participants in the adult changes in thought study, Seattle, Washington. USEPA Public Docket AR-226-1084.
47. Olsen, G.W., Burris, J.M., Lundberg, Hansen, K.J., Mandel, J.H., Zobel, L.R., 2002b. Identification of fluorochemicals in human sera. III. Pediatric participants in a group A Streptococci clinical trial investigation. USEPA Public Docket AR-226-1085.
48. Olsen G.W., Hansen K.J., Stevenson L.A., Burris J.M., Mandel J.H. Human donor liver and serum concentrations of perfluorooctanesulfonate (PFOS) and other perfluorochemicals. Environ. Sci. Technol. 37:2003a;888-891.
49. Olsen G.W., Church T.R., Miller J.P., Burris J.M., Hansen K.J., Lundberg J.K., Armitage J.B., Herron R.M., Medhdizadehkashi Z., Nobiletti J.B., O'Neill E., Mandel J.H., Zobel L.R. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 111:2003;1892-1901.
50. Olsen G.W., Church T.R., Larson E.B., van Belle G., Lundberg J.K., Hansen K.J., Burris J.M., Mandel J.H., Zobel L.R. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in elderly population from Seattle, Washington. Chemosphere. 54:2004;1599-1611.
51. Pastoor T.P., Lee K.P., Perri M.A., Gillies P.J. Biochemical and morphological studies of ammonium perfluorooctonate-induced hepatomegaly and peroxisome proliferation. Exp. Mol. Pathol. 47:1987;98-109.
52. Permadi H., Lundgren B., Anderson K., DePierre J.W. Effects of perfluoro fatty acids in xenobiotic-metabolizing enzymes, enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver. Biochem. Pharmacol. 44:1992;1183-1191.
53. Riker Pharmaceuticals, 1983. Two year oral (diet) toxicity/ carcinogenicity study of fluorochemical FC-143 in rats. Riker Laboratories, Inc., Experiment No. 0281CR0012, May 1983. USEPA Public Docket AR-226-0437, 226-0438, 226-0439, 226-0440.
54. Robba C., Mazzocchi G., Gottardo G., Nussdorfer G.G. Effects of the hypolipidemic drug nafenopin on the zona glomerulosa of the rat adrenal cortex morphological counterparts of functional alterations. Anat. Anz. 161(1):1986;35-41.
55. Ronnekleiv O.K., Ojeda S.R., McCann S.M. Undernutrition, puberty, and the development of estrogen positive feedback in the female rat. Biol. Reprod. 19:1978;414-424.
56. Schneider G., Kirschner M.A., Berkowitz R., Ertel N.H. Increased estradiol production in obese men. J. Clin. Endocrinol. Metab. 48:1979;633-638.
57. Siegel, S., 1956. Nonparametric Statistics for the Behavioral Sciences. McGraw-Hill, New York, pp. 96-104.
58. Snedecor, G.W., Cochran, W.G., 1967a. Variance Test for Homogeneity of the Binomial Distribution. Statistical Methods, sixth ed. Iowa State University Press, Ames, pp. 240-241.
59. Snedecor, G.W., Cochran, W.G., 1967b. Analysis of Variance. Statistical Methods, sixth ed. Iowa State University Press, Ames, pp. 258-275.
60. Sokal, R.R., Rohlf, F.J., 1969a. Bartlett's Test of Homogeneity of Variances. Biometry. W.H. Freeman and Co., San Francisco, pp. 370-371.
61. Sokal, R.R., Rohlf, F.J., 1969b. Kruskal-Wallis Test. Biometry. W.H. Freeman and Co., San Francisco, pp. 388-389.
62. Staples R.E., Burgess B.A., Kerns W.D. The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. Fundam. Appl. Toxicol. 4:1984;429-440.
63. Staples R.E. The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. Fundam. Appl. Toxicol. 4:1985;429-440.
64. Stoker T.E., Laws S.C., Guidici D.L., Cooper R.L. The effect of atrazine on puberty in male Wistar rats: an evaluation in the protocol for assessment of pubertal development and thyroid function. Toxicol. Sci. 58:2000a;50-59.
65. Stoker T.E., Parks L.G., Gray L.E., Cooper R.L. Endocrine-disrupting chemicals: prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Crit. Rev. Toxicol. 30:2000b;197-252.
66. Taves, D., Guy, W., Brey, W., 1976. Organic fluorocarbons in human plasma: prevalence and characterization. In: Filler, R. (Ed.), Biochemistry Involving Carbon-Fluorine Bonds. American Chemical Society, Washington, DC, pp. 117-134.
67. Ubel F.A., Sorenson S.D., Roach D.E. Health status of plant workers exposed to fluorochemicals - a preliminary report. Am. Ind. Hyg. Assoc. J. 41:1980;584-589.
68. USEPA, 2002. Revised draft. Hazard assessment of perfluorooctanoic acid and its salts. USEPA Public Docket AR-226.
69. Vanden Heuvel J., Kuslikis B., Van Rafelghem M. Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. Biochem. Toxicol. 6:1991;83-92.
70. Vanden Heuvel J.P., Kuslikis B.I., Peterson R.E. Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats. Chem.-Biol. Interact. 82:1992;317-328.
71. Widdowson E.M., McCance R.A. Some effects of accelerating growth. I. General somatic development. Proc. Roy. Soc. B. 152:1960;188-206.
72. York, R., 1999a. Final report: combined oral (gavage) fertility, developmental and perinatal/postnatal reproduction toxicity study of N-EtFOSE in rats. Argus Research Laboratories Protocol No. 418-009. USEPA Pubic Docket AR-226-0554.
73. York, R., 1999b. Final report: combined oral (gavage) fertility, developmental and perinatal/postnatal reproduction toxicity study of PFOS in rats. Argus Research Laboratories Protocol 418-008. USEPA Public Docket 226-0563.